14/27 (52%) patients had PIK3CA detected in peripheral blood (Guardant 360 testing), and 13/27 (48%) had PIK3CA detected on tumor tissue (Omniseq, Foundation One). The gene discussed is PIK3CA; the disease is neoplasm.